{"name":"Dantari, Inc.","slug":"dantari-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOY1phNkcyY0padUhuUUh5cU1ZWW9XSGk5TV9vMDRyemk2WlJ1ZUE1M3hZbUU3T2QtYmZjVjZ3TlE4QW1FdWs0WnJmS2cwTUZlMFhyd2JoZFhSWWNXZTZNaVFDVFJqLWJUdXd0MGpaNlBEX1hyRWRmelVlNFoxQ2lXbGdLeTVaSlhGZjJFZ3RpaDNsQk5zUVpIRHh3WmVXODQ5TGtPYkV6d0dIQUU?oc=5","date":"2025-01-24","type":"trial","source":"Endpoints News","summary":"Boehringer merges cancer vaccine and oncolytic virus teams; Dantari sells off assets - Endpoints News","headline":"Boehringer merges cancer vaccine and oncolytic virus teams; Dantari sells off assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQSDk4TlpLR0VZY2psRk5rNHNIdFVCQ2VmaTZVRm01bXJoRzFDZFFKMVJ0c3NUQ2ZmSkc5X0M5cnc0UjJPR1pfYVZEMXJDTGpnOFhFMlB5bmFHaTd2dkhDVm41bU1MUFhfeExiQk9TSXgtR2hlUmxXZllOblFJcHhuWUVldEs1ZENOMWJkUkdXWThZNjlHd3hmOFpnUkNLV24wdzdaR0xuM2VXelFnWG1OMjBtZENUb3BTbUVIVkRqQnpzYjdGNEYxODRSQVpRbXZITTU1cUo0NG1lcjZFemFmaXg1T18zOXk5cEhjQXIzc0JVTTZVWHJXb1dpMG9LbTJ4QUtRd01NSWpPWDY5d0FZNUtZVmp6ellENGJSYzVTZ2luVGNM?oc=5","date":"2023-12-07","type":"pipeline","source":"PR Newswire","summary":"Dantari's Novel High-Capacity Drug Conjugate DAN-222 Shows Promising Antitumor Activity in Patients with Metastatic HER2-Negative Breast Cancer - PR Newswire","headline":"Dantari's Novel High-Capacity Drug Conjugate DAN-222 Shows Promising Antitumor Activity in Patients with Metastatic HER2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQT0hQMUNOUkhtOC1KVlBjNGRuM2l1N2I2MC02Yk5ZLUdiYU4wUnRaV1pQRGt6QkZsbFMzYUF3Ymw3cFduRXh2MmNDY0Z0cmNNM08wYUExNDVQRzRNZDJpelNNQ1VoYmFRSGV2WGpBTWc4Ri0xem8tVFU5RElpbnU4bm5CWm1XcHk4YXRV?oc=5","date":"2023-06-29","type":"deal","source":"BioPharma Dive","summary":"Lilly to acquire cancer antibody drug startup Emergence - BioPharma Dive","headline":"Lilly to acquire cancer antibody drug startup Emergence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPcnplcmc4aUFnRXJoMDhPcXk0Mm1rY2lBTFBEY0w1WUpzNlI0b2t0U3E2UFJodzBCemQzcE51ZUNySjhlX0pvbExfTjVsZEY3MHBfbmhwZ0c0LVU4OWlWRWVXMzlTQUVEQmtoVGZuVE5UN3FIb3pGMWFQelVIZUJYa0Y4Tk1Kd28?oc=5","date":"2022-12-08","type":"pipeline","source":"BioPharma Dive","summary":"Dantari emerges with a new way to make cancer drug conjugates - BioPharma Dive","headline":"Dantari emerges with a new way to make cancer drug conjugates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNNHlzVThWc1U3dUNMdUttOWF4NUlsTTdXZkdDenNiWC1QM0d3S0w2QXMxQklBZTM0bzh0N1VTbU9lR21fVWJZQk9WZzBqXzhCQ0I1OXRPZi1UdjlSTnBmUDRZQkpicXFHTl9BTGhhTTFtRlBaMjl6ajNXZHctM0pyZW1RUHVMNDJhdVoybm1rbEpCUWxhVjA5bjl5bzI3dzRoam1nQ2dfOTAxRF9vMHdfM0UzSmVTRXdVa0NOTF9xUXFjY1l4MDlWeTlmOU12SDM1UDhaNEZMS0VRVWthRjJEblZyZFB0dmU5N2VQaA?oc=5","date":"2022-12-08","type":"pipeline","source":"PR Newswire","summary":"Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors - PR Newswire","headline":"Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}